Consolidated Statement of Operations (USD $)	3 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Revenues:
Hypertension royalties	$ 1,200
Total Revenues	1,200
Cost of Sales-plastic processing	38,258
Gross Profit	(37,058)
Expenses:
Selling, general and administrative	202,473	65,096
Total Expenses	202,473	65,096
Operating loss	(239,531)	(65,096)
Other Income:
Interest income	2,096	1,995
Miscellaneous income	499
Total Other Income	2,595	1,995
Net loss before income taxes	(236,936)	(63,101)
Net loss from continuing operations	(236,936)	(63,101)
Income Loss from discontinued operations	(651,362)	327,322
Loss on sale of discontinued operations	(123,702)
Net income (loss) from discontinued operations	(775,064)	327,322
Net income (loss)	$ (1,012,000)	$ 264,221
Earnings Per Share
Basic income (loss) from continuing operations per share
Diluted income (loss) from continuing operations per share
Net Income (loss) from discontinuing operations:
Basic income (loss) from discontinuing operations per share	$ (0.02)	$ 0.01
Diluted income (loss) from discontinuing operations per share	$ (0.02)	$ 0.01
Net Income (loss) per Common Share:
Basic income (loss) per common share	$ (0.02)	$ 0.01
Diluted income (loss) per common share	$ (0.02)	$ 0.01
Weighted Average Common Shares Outstanding, Basic	43,325,843	41,995,526
Weighted Average Common Shares Outstanding, Diluted	43,325,843	41,995,526